BML Health is excited to welcome Ela Borenstein, Vice President Venture Capital Incentivized Programs at the BDC, to share her insights on the Canadian MedTech investment landscape. Come and join us on Thursday, March 21st, 2024 from 5:00 PM to 7:00 PM in downtown Montreal, to get a better understanding for how Canadian MedTech startups can work together with the Canadian medical technology ecosystem to obtain greater funding and support.
Canada has a dynamic, skilled and promising medical technology ecosystem but Canadian MedTech startups consistently struggle to raise funds deserving of their potential. Theories abound as to why: market size, risk aversion, lack of available funds, and others. Ela Borestein is on the front lines of venture capital and early stage investing in Canada at the BDC – one of the most active venture investors in the country and often the lead investor in early stage funding rounds. Gain insights from Ela on how the Canadian ecosystem can better support its own medtech startups to see them compete on the world stage.
Cocktail and Presentations: By invitation Only
WHEN: Thursday, March 21st, 2024 at 5 to 7 PM
WHERE: The Church of St John the Evangelist, 137 President Kennedy Ave, Montreal, QC H2X 3P6.
Find out more.
By invitation Only
The event is exclusive to BML Health, SeR and CTS guests that include startup founders, investors, accelerators, university research groups, Montreal life sciences community stakeholders, and the Quebec and Canadian governments.
About Ela Borestein
Ela is Vice President leading the VCIP team, where she is responsible for incentivized and mandated programs on behalf of the government, notably, Venture Capital Action Plan (VCAP), Venture Capital Catalyst Initiative (VCCI) 2017, renewed VCCI, and the Covid Bridge Financing programs, totaling $1.8B for the development and launch of new initiatives for Canadian funds.
She joined BDC Capital in 2007 spending 9 years as an investor in healthcare and life sciences companies bringing over 20 years of management, entrepreneurial and consulting experience in the biopharmaceutical and related industries.
Prior to joining BDC, she was Chief Operating Officer at a VC-backed biotech firm. She previously held the position of Vice President in clinical, regulatory affairs and product strategy for various public and private companies, including during a successful IPO. Her diversified professional background includes senior management responsibilities in drug and medical device development as well as key involvement in product acquisition and M&A activities.
Ela holds a Bachelor of Science in Chemistry from the University of Western Ontario, a Master of Science in Pharmacology from the University of Toronto and an MBA in Bio-Industries from Université du Québec à Montréal. She is also an advisor and guest lecturer with several organizations and Universities, including McGill.
Check out videos from some of our recent Medtech 5 à 7 events:
US Fundraising Strategies for Canadian Digital Health Startups
US Market Entry for Canadian Health Startup
About Desjardins Startup en Residence
The Desjardins Accelerator Startup in Residence Program invests in and provides support for startups that have a positive socio-economic impact within Canada. Startup in Residence is designed to guide early-stage, growth-driven companies to market success.
startup-residence.ca/en/
About CTS Santé
The growth accelerator for healthcare technology. Specialized in innovative healthcare technology and digital health solutions, CTS is an à la carte growth accelerator who responds to the particular challenges and needs of each startup. With CTS behind you, you’ll get strategic coaching to secure financing, effective commercialization tools that will help you succeed across Canada and internationally, and an introduction to their dynamic ecosystem of key medical and business players.
ctssante.com/en/
About BDC Capital
The Business Development Bank of Canada is the bank for Canadian entrepreneurs. BDC helps create and develop strong Canadian businesses through financing, advisory services and capital, with a focus on small and medium-sized enterprises. BDC understands the challenges of growing an innovative business and is actively supporting more than 4,000 Canadian tech entrepreneurs, with more than $4B in loans and investments.
bdc.ca/en/bdc-capital
View our comprehensive list of Montreal based digital health and medical technology angels, incubators, accelerators, venture capital investors and other financing resources for digital health startups.
About BML Health
BML Health understands digital health. At the intersection of medical technology, clinical research and patient-centric healthcare BML drives the mainstream adoption of digital technology in healthcare. Offering a full range of services to the digital health ecosystem BML manages the complex stakeholder interactions necessary to get digital health solutions to market and gain adoption.
Stay Connected with BML Technology.
Connect with BML Technology on LinkedIn.
